GluR5 kainate receptors, seizures, and the amygdala

Annals of the New York Academy of Sciences

Volumn 985, Issue , 2003, Pages 150-162

  Rogawski, Michael A ^a   Gryder, Divina ^a   Castaneda, Dora ^a   Yonekawa, Wayne ^a   Banks, Melissa K ^a   Li, He ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

AMPA receptor; Amygdala; ATPA; Epilepsy; GluR5 kainate receptor; LY293558; Synaptic plasticity; Synaptic transmission; Topiramate

Indexed keywords

ALPHA AMINO 5 TERT BUTYL 3 HYDROXY 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; KAINIC ACID RECEPTOR; TOPIRAMATE;

AMYGDALOID NUCLEUS; BRAIN SLICE; CONFERENCE PAPER; EPILEPTIC STATE; EPILEPTOGENESIS; LIMBIC SYSTEM; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; SEIZURE;

ANIMALIA;

EID: 0037279320     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07079.x     Document Type: Conference Paper

References (62)

1. GLOOR, P. 1992. Role of the amygdala in temporal lobe epilepsy. In The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. J.P. Aggleton, Ed.:505-538. Wiley-Liss. New York.
2. GODDARD, G.V. 1967. Development of epileptic seizures through brain stimulation at low intensity. Nature 214: 1020-1021.
3. LE GAL LA SALLE, G. 1981. Amygdaloid kindling in the rat: regional differences and general properties. In Kindling 2. J.A. Wada, Ed.:227-237. Raven Press. New York.
4. GEAN, P.W. & P. SHINNICK-GALLAGHER. 1988. Characterization of the epileptiform activity induced by magnesium-free solution in rat amygdala slices: an intracellular study. Exp. Neurol. 101: 248-255.
5. RAINNIE, D.G., E.K. ASPRODINI & P. SHINNICK-GALLAGHER. 1992. Kindling-induced long-lasting changes in synaptic transmission in the basolateral amygdala. J. Neurophysiol. 67: 443-454.
6. BURNHAM, W.M. 1975. Primary and "transfer" seizure development in the kindled rat. Can. J. Neurol. Sci. 2: 417-428.
7. KAIRISS, E.W., R.J. RACINE & G.K SMITH. 1984. The development of the interictal spike during kindling in the rat. Brain Res. 322: 101-110.
8. BEN-ARI, Y. 1985. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375-403.
9. CHIAMULERA, C., S. COSTA, E. VALERIO & A. REGGIANI. 1992. Domoic acid toxicity in rats and mice after intracerebroventricular administration: comparison with excitatory amino acid agonists. Pharmacol. Toxicol. 70: 115-120.
10. NADLER, J.V. 1981. Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci. 29: 2031-2042.
11. SCHWOB, J.E., T. FULLER, J.L. PRICE & J.W. OLNEY. 1980. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience 5: 991-1014.
12. TUUNANEN, J., T. HALONEN & A. PITKÄNEN. 1996. Status epilepticus causes selective regional damage and loss of GABAergic neurons in the rat amygdaloid complex. Eur. J. Neurosci. 8: 2711-2725.
13. BEN-ARI, Y., J. LAGOWSKA, E. TREMBLAY & G. LE GAL LA SALLE. 1979. A new model of focal status epilepticus: intra-amygdaloid application of kainic acid elicits repetitive secondary generalized convulsive seizures. Brain Res. 163: 176-179.
14. TANAKA, S., S. KONDO, T. TANAKA & Y. YNEMASU. 1988. Long-term observation of rats after unilateral intra-amygdaloid injection of kainic acid. Brain Res. 463: 163-167.
15. DINGLEDINE, R., K. BORGES, D. BOWIE & S.F. TRAYNELIS. 1999. The glutamate receptor ion channels. Pharmacol. Rev. 51: 7-61.
16. BLEAKMAN, D. 1999. Kainate receptor pharmacology and physiology. CMLS, Cell. Mol. Life Sci. 56: 558-566.
17. LI, H. & M.A. ROGAWSKI. 1998. GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro. Neuropharmacology 37: 1279-1286.
18. WILDING, T.J. & J.E. HUETTNER. 1995. Differential antagonism of AMPA-preferring and kainate-preferring receptors by 2,3-benzodiazepines. Mol. Pharmacol. 47: 582-587.
19. PATNEAU, D.K. & M.L. MAYER. 1990. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J. Neurosci. 10: 2385-2399.
20. LERMA, J., A.V. PATERNAIN, J.R. NARANJO & B. MELLSTROM. 1993. Functional kainateselective glutamate receptors in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA 90: 11688-11692.
21. CLARKE, V.R., B.A. BALLYK, K.H. HOO, et al. 1997. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389: 599-603.
22. CUI, C. & M.L. MAYER. 1999. Heteromeric kainate receptors formed by the coassembly of GluR5, GluR6, and GluR7. J. Neurosci. 19: 8281-8291.
23. STENSBØL, T.B., L. BORRE, T.N. JOHANSEN, et al. 1999. Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA. Eur. J. Pharmacol. 380: 153-162.
24. PATERNAIN, A.V., M.T. HERRERA, M.A. NIETO & J. LERMA. 2000. GluR5 and GluR6 kainate receptor subunits coexist in hippocampal neurons and coassemble to form functional receptors. J. Neurosci. 20: 196-205.
25. K5 receptor selective agonist, on excitatory synaptic transmission in area CA1 of rat hippocampal slices. Neuropharmacology 42: 889-902.
26. DONEVAN, S.D. & M.A. ROGAWSKI. 1993. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10: 51-59.
27. PATERNAIN, A.V., M. MORALES & J. LERMA. 1995. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 14: 185-189.
28. BLEAKMAN, R., D.D. SCHOEPP, B. BALLYK, et al. 1996. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisdoquinoline-3 carboxylic-acid. Mol. Pharmacol. 49: 581-585.
29. SIMMONS, R.M., D.L. LI, K.H. HOO, et al. 1998. Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology 37: 25-36.
30. O'NEILL, M.J., A. BOND, P.L. ORNSTEIN, et al. 1998. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. Neuropharmacology 37: 1211-1222.
31. WISDEN, W. & P.H. SEEBURG. 1993. A complex mosaic of high-affinity kainate receptors in rat brain. J. Neurosci. 13: 3582-3598.
32. LI, H., A. CHEN, G. XING, et al. 2001. Kainate receptor-mediated heterosynaptic facilitation in the amygdala. Nat. Neurosci. 4: 612-620.
33. FRERKING, M. & R.A. NICOLL. 2000. Synaptic kainate receptors. Curr. Opin. Neurobiol. 10: 342-351.
34. LERMA, J., A.V. PATERNAIN, A. RODRÍGUEZ-MORENO, et al. 2001. Molecular physiology of kainate receptors. Physiol. Rev. 81: 971-998.
35. MALENKA, R.C. & R.A. NICOLL. 1999. Long-term potentiation - a decade of progress? Science 285: 1870-1874.
36. FISHER, R.S. & B.E. ALGER. 1984. Electrophysiological mechanisms of kainic acid-induced epileptiform activity in the rat hippocampal slice. J. Neurosci. 4: 1312-1323.
37. BENEDIKZ, E., P. CASACCIA-BONNEFIL, A. STELZER & P.J. BERGOLD. 1993. Hyperexcitability and cell loss in kainate-treated hippocampal slice cultures. Neuroreport 5: 90-92.
38. JIMBO, Y. & H.P. ROBINSON. 2000. Propagation of spontaneous synchronized activity in cortical slice cultures recorded by planar electrode arrays. Bioelectrochemistry 51: 107-115.
39. ROGAWSKI, M.A. & S.D. DONEVAN. 1999. AMPA receptors in epilepsy and as targets for antiepileptic drugs. Adv. Neurol. 79: 947-963.
40. LÖSCHER, W. & M.A. ROGAWSKI. 2002. Epilepsy. In Ionotropic Glutamate Receptors As Therapeutic Targets. D. Lodge, W. Danysz & C.G. Parsons, Eds.: 91-132. F.P. Graham Publishing Co. Johnson City, TN. In press.
41. GIBBS, J.W., 3RD, S. SOMBATI, R.J. DELORENZO & D.J. COULTER. 2000. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41 (Suppl 1): S10-16.
42. OGDEN, A.M.L, P. BAUMBARGER, M. GATES, et al. 2002. Topiramate actions at ligand and voltage-gated ion channels in vitro. The Pharmacologist 44 (Suppl 1): A257 (XIVth World Congress of Pharmacology Abstr. 143.12).
43. SHANK, R.P., J.F. GARDOCKI, A.J. STREETER & B.E. MARYANOFF. 2000. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41 (Suppl 1): S3-9.
44. CHAPMAN, P.F., E.W. KAIRISS, C.L. KEENAN & T.H. BROWN. 1990. Long-term synaptic potentiation in the amygdala. Synapse 6: 271-278.
45. MAREN, S. & M.S. FANSELOW. 1995. Synaptic plasticity in the basolateral amygdala induced by hippocampal formation stimulation in vivo. J. Neurosci. 15: 7548-7564.
46. ARONIADOU-ANDERJASKA, V., R.M. POST, M.A. ROGAWSKI & H. LI. 2001. Input-specific LTP and depotentiation in the basolateral amygdala. Neuroreport 12: 635-640.
47. MAREN, S. 2001. Neurobiology of Pavlovian fear conditioning. Annu. Rev. Neurosci. 24: 897-931.
48. HUANG, Y.Y. & E.R. KANDEL. 1998. Postsynaptic induction and PKA-dependent expression of LTP in the lateral amygdala. Neuron 21: 169-178.
49. WEISSKOPF, M.G., E.P. BAUER & J.E. LEDOUX. 1999. L-type voltage-gated calcium channels mediate NMDA-independent associative long-term potentiation at thalamic input synapses to the amygdala. J. Neurosci. 19: 10512-10519.
50. LI, H., S.R. WEISS, D.M. CHUANG, et al. 1998. Bidirectional synaptic plasticity in the rat basolateral amygdala: characterization of an activity-dependent switch sensitive to the presynaptic metabotropic glutamate receptor antagonist 2S-α-ethylglutamic acid. J. Neurosci. 18: 1662-1670.
51. ROGAWSKI, M.A., P.S. KURZMAN, S. YAMAGUCHI & H. LI. 2001. Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse. Neuropharmacology 40: 28-35.
52. BANKS, M.K. & M.A. ROGAWSKI. 2001. A role for GluR5 kainate receptors in the epileptogenic effects of kainate. Soc. Neurosci. Abstr. 27: 558.2.
53. MULLE, C., A. SAILER, I. PEREZ-OTANO, et al. 1998. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 392: 601-605.
54. VISSEL, B., G.A. ROYLE, B.R. CHRISTIE, et al. 2001. The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron 29: 217-227.
55. SAILER, A., G.T. SWANSON, I. PEREZ-OTANO, et al. 1999. Generation and analysis of GluR5(Q636R) kainate receptor mutant mice. J. Neurosci. 19: 8757-8764.
56. PEREZ-OTANO, I., A. SAILER, S. PETERS, et al. 2001. Differential susceptibility of GluR6 knockout mice to seizures in animal models of temporal lobe epilepsy. Soc. Neurosci. Abstr. 27: 558.1.
57. BEN-ARI, Y. & R. COSSART. 2000. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 23: 580-587.
58. RODRIGUEZ-MORENO, A. & J. LERMA. 1998. Kainate receptor modulation of GABA release involves a metabotropic function. Neuron 20: 1211-1218.
59. KULLMANN, D.M. 2001. Presynaptic kainate receptors in the hippocampus: slowly emerging from obscurity. Neuron 32: 561-564.
60. CONTRACTOR, A., G.T. SWANSON, A. SAILER, et al. 2000. Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus. J. Neurosci. 20: 8269-8278.
61. SCHMITZ, D., J. MELLOR, M. FRERKING & R.A. NICOLL. 2001. Presynaptic kainate receptors at hippocampal mossy fiber synapses. Proc. Natl. Acad. Sci. USA 98: 11003-11008.
62. CONTRACTOR, A., G. SWANSON & S.F. HEINEMANN. 2001. Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus. Neuron 29: 209-216.